Skip to content
Est. 1998 proudly celebrating 27 years of standing behind American companies
American Origin Unverified This profile is unclaimed and has not been independently reviewed. Claim & get verified

VOLITIONRX LTD (VNRX)

$1.00 -7.41% NYSE: VNRX · 15-min delayed
  • HENDERSON, Nevada
  • Public · NYSE: VNRX
  • 75 employees
$15.4MMarket cap
$1.7MRevenue · FY2025
-$23.4MNet income
75Employees
VNRXNYSE
2007IPO

About VOLITIONRX LTD

VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor range of life-altering diseases including some cancers and diseases associated with NETosis. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on diagnostics and monitoring.

This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.

Reported figures

Financial summary

Revenue FY2025
$1.7M
Net income
-$23.4M
Total assets
$6.9M
Market cap
$15.4M
Operating margin
-1258.5%
Net margin
-1360.6%

Source: SEC EDGAR · updated Jun 7, 2026

Multi-year

Revenue & profit trend

Revenue Net income
FY 2025

Financial statements

Income statement

Revenue
$1.7M
Operating expenses
$23.5M
Operating income
-$21.7M
Income tax
$19
Net income
-$23.5M

Balance sheet

Total assets
$6.9M
Current assets
$2.1M
Total liabilities
$42.5M
Current liabilities
$12.2M
Shareholders’ equity
-$35.6M

Cash flow

Operating cash flow
-$19.7M
Investing cash flow
-$89.6K
Financing cash flow
$17.1M
Net cash flow
-$2.1M

Statements via Polygon.io (SEC filings)

NYSE: VNRX
$1.00 -7.41%

15-minute delayed · data by Polygon.io

Past year · hover for prices

$1.00 $18.40

52-week range

Market cap
$15.4M
Shares outstanding
15.4M
Open
Day range
Prev close
Volume
IPO date
Apr 25, 2007

Volitionrx Ltd (VNRX) Stock Price

  • Reported a net loss of $23.4M in FY2025.
  • Revenue grew 1819% from FY2021 to FY2025.
  • Trading 95% below its 52-week high.

Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.

No reviews yet. Be the first to review VOLITIONRX LTD.

Write a review
Newsroom

News about VOLITIONRX LTD

News & sentiment via Polygon.io

FAQ

Volitionrx Ltd: frequently asked questions

Is Volitionrx Ltd an American company?

Volitionrx Ltd is a US-based company headquartered in Henderson, Nevada, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.

Where is Volitionrx Ltd headquartered?

Volitionrx Ltd is headquartered in Henderson, Nevada, United States.

Is Volitionrx Ltd publicly traded?

Yes — Volitionrx Ltd is a publicly traded company. Its stock trades under the ticker symbol VNRX on the NYSE.

What does Volitionrx Ltd do?

Volitionrx Ltd is an American Medical Devices company in the Health & Beauty sector.

Explore

Similar companies

Browse all →